Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data.
Sameh GomaaW Kevin KellyEdith MitchellEugene StorozynskyCharnita Zeigler-JohnsonHee-Soon JuonKuang-Yi WenPublished in: World journal of urology (2023)
ADT exposure increases the risk of NODM in men with PCa, especially among AA men compared with Caucasian men. Men receiving ADT should be monitored routinely for signs and symptoms of metabolic syndrome and diabetes. Targeted close monitoring of AA men on ADT would be critical to prevent and treat metabolic complications with potential of reducing disparities in PCa morbidity.
Keyphrases
- prostate cancer
- middle aged
- metabolic syndrome
- end stage renal disease
- cardiovascular disease
- newly diagnosed
- chronic kidney disease
- stem cells
- ejection fraction
- glycemic control
- risk factors
- electronic health record
- radical prostatectomy
- depressive symptoms
- risk assessment
- african american
- drug delivery
- weight loss
- skeletal muscle
- big data
- deep learning
- artificial intelligence
- cell therapy
- affordable care act
- data analysis
- bone marrow